General Information


DRACP ID  DRACP03946

Peptide Name  

Sequence  RR

Sequence Length  2

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C18

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C12H26N8O3

Absent amino acids  ACDEFGHIKLMNPQSTVWY

Common amino acids  R

Mass  34840

Pl  12.5

Basic residues  2

Acidic residues  0

Hydrophobic residues  0

Net charge  2

Boman Index  -2984

Hydrophobicity  -450

Aliphatic Index  0

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31936341

Title  Ultrashort Cationic Lipopeptides-Effect of N-Terminal Amino Acid and Fatty Acid Type on Antimicrobial Activity and Hemolysis

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14905

DRACP is developed by Dr.Zheng's team.